Roderick Wong
@Rtw Investments, Lp
Latest period2024 - Q3ReportedManaged Assets$6.911BTotal holdings68
Assets growth rate7%Assets growth rate (2-Q avg)1.18%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Rtw Investments, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 68 positions.
Assets under management
The assets under management (AUM) of Rtw Investments, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 6.911B in assets, with a quarterly growth rate of 7% and a 2-quarter average growth rate of 1.18%. The portfolio is managed by Roderick Wong, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
XNCRXencor Inc
| 0.17% | $11.563M 575,000 shares@ $20.11 avg price | New Position |
TXG10x Genomics Inc
| 0.17% | $11.354M 502,856 shares@ $22.58 avg price | |
IMUXImmunic Inc
| 0.11% | $7.537M 4.568M shares@ $1.65 avg price | |
PCSCPerceptive Cap Solutions Cor
| 0.11% | $7.432M 742,500 shares@ $10.01 avg price | |
WVEWave Life Sciences Ltd
| 0.11% | $7.38M 900,000 shares@ $8.2 avg price | New Position |
IDYAIdeaya Biosciences Inc
| 0.1% | $6.336M 200,000 shares@ $31.68 avg price | New Position |
GPCRStructure Therapeutics Inc
| 0.08% | $5.486M 125,000 shares@ $43.89 avg price | |
MISTMilestone Pharmaceuticals In
| 0.08% | $4.949M 3.256M shares@ $1.52 avg price | |
SLRNAcelyrin Inc
| 0.07% | $4.823M 978,310 shares@ $4.93 avg price | |
XGNExagen Inc
| 0.07% | $4.672M 1.512M shares@ $3.1 avg price |